Stericycle, Inc. (NASDAQ:SRCL) Shares Acquired by Cerity Partners LLC

Cerity Partners LLC lifted its position in shares of Stericycle, Inc. (NASDAQ:SRCL) by 145.0% during the fourth quarter, HoldingsChannel reports. The firm owned 33,532 shares of the business services provider’s stock after purchasing an additional 19,846 shares during the quarter. Cerity Partners LLC’s holdings in Stericycle were worth $1,662,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in the company. Vanguard Group Inc. lifted its position in shares of Stericycle by 1.6% during the third quarter. Vanguard Group Inc. now owns 8,681,888 shares of the business services provider’s stock worth $365,594,000 after purchasing an additional 139,456 shares in the last quarter. Alliancebernstein L.P. lifted its position in shares of Stericycle by 1.8% during the fourth quarter. Alliancebernstein L.P. now owns 6,963,391 shares of the business services provider’s stock worth $347,404,000 after purchasing an additional 124,712 shares in the last quarter. Clarkston Capital Partners LLC lifted its position in shares of Stericycle by 0.8% during the third quarter. Clarkston Capital Partners LLC now owns 6,524,331 shares of the business services provider’s stock worth $291,703,000 after purchasing an additional 52,087 shares in the last quarter. Black Creek Investment Management Inc. lifted its position in shares of Stericycle by 1.1% during the third quarter. Black Creek Investment Management Inc. now owns 5,493,782 shares of the business services provider’s stock worth $245,627,000 after purchasing an additional 62,400 shares in the last quarter. Finally, Capital Research Global Investors lifted its position in shares of Stericycle by 1.2% during the first quarter. Capital Research Global Investors now owns 4,396,958 shares of the business services provider’s stock worth $259,069,000 after purchasing an additional 51,885 shares in the last quarter. 98.82% of the stock is owned by institutional investors and hedge funds.

Stericycle Price Performance

Stericycle stock opened at $49.91 on Friday. The firm’s 50-day moving average is $51.41 and its 200-day moving average is $47.95. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.94 and a current ratio of 0.94. Stericycle, Inc. has a 1 year low of $37.78 and a 1 year high of $57.06.

Stericycle (NASDAQ:SRCL) last posted its quarterly earnings results on Wednesday, February 28th. The business services provider reported $0.54 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.47 by $0.07. Stericycle had a negative net margin of 0.80% and a positive return on equity of 7.06%. The company had revenue of $652.00 million for the quarter, compared to the consensus estimate of $657.99 million. During the same period last year, the firm posted $0.60 EPS. The company’s revenue for the quarter was down 2.7% on a year-over-year basis. As a group, research analysts forecast that Stericycle, Inc. will post 2.31 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of research analysts have commented on SRCL shares. Truist Financial increased their price objective on shares of Stericycle from $50.00 to $57.00 and gave the company a “hold” rating in a research note on Thursday, February 29th. StockNews.com downgraded shares of Stericycle from a “buy” rating to a “hold” rating in a research note on Tuesday, April 2nd. Stifel Nicolaus increased their price objective on shares of Stericycle from $70.00 to $75.00 and gave the company a “buy” rating in a research note on Thursday, February 29th. Royal Bank of Canada reiterated an “outperform” rating and set a $69.00 price objective on shares of Stericycle in a research note on Thursday, March 7th. Finally, Wells Fargo & Company increased their price objective on shares of Stericycle from $40.00 to $48.00 and gave the company an “underweight” rating in a research note on Friday, March 1st. One analyst has rated the stock with a sell rating, two have issued a hold rating and two have given a buy rating to the company. According to data from MarketBeat, Stericycle presently has an average rating of “Hold” and a consensus target price of $62.25.

About Stericycle

Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.